NASDAQ
Decibel Therapeutics, Inc. (DBTX) has a free cash flow growth of 40.79% as of Friday, May 29, 2026. This represents a 525.88% increase compared to its 12-month average of -9.58%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.